Evaluation of the binding characteristics of [18F]fluoroproxyfan in the rat brain for in vivo visualization of histamine H3 receptor

Nuclear Medicine and Biology

Volumn 34, Issue 8, 2007, Pages 981-987

  Funaki, Yoshihito ^a   Sato, Kimihiko ^a   Kato, Motohisa ^b   Ishikawa, Yoichi ^a   Iwata, Ren ^a   Yanai, Kazuhiko ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoradiography; Binding; Biodistribution; Fluoroproxyfan; Histamine H3 receptor; Positron emission tomography (PET)

Indexed keywords

3 (1H IMIDAZOL 4 YL)PROPYL 4 FLUOROBENZYL ETHER F 18; BENZYL BROMIDE F 18; FLUOROPROXYFAN F 18; HISTAMINE H3 RECEPTOR; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; DRUG BINDING; DRUG DISTRIBUTION; IN VIVO STUDY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; RECEPTOR BINDING;

ANIMALS; BRAIN; DRUG EVALUATION, PRECLINICAL; IMIDAZOLES; ISOTOPE LABELING; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, HISTAMINE H3; TISSUE DISTRIBUTION;

EID: 35848944099     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.07.012     Document Type: Article

References (36)

1. Hough L.B. Genomics meets histamine receptors: new subtypes, new receptors. Mol Pharmacol 59 (2001) 415-419
2. 3) of histamine receptor. Nature 302 (1983) 832-837
3. 3-receptors. Nature 327 (1987) 117-123
4. 3-receptors control histamine release in human brain. J Neurochem 51 (1988) 105-108
5. 3 receptor. Mol Pharmacol 55 (1999) 1101-1107
6. 3 autoreceptors modulate histamine synthesis through cAMP pathway. Mol Pharmacol 61 (2002) 239-245
7. 3 heteroreceptors. Fundam Clin Pharmacol 8 2 (1994) 128-137
8. Watanabe T., Timmerman H., and Yanai K. Histamine research in the new millennium. International Congress Series No. 1224 (2001), Elsevier Science B.V., Amsterdam, The Netherlands
9. -/- mice. Eur J Neurosci 19 (2004) 1992-1996
10. 3 receptor agonists and antagonists. Trends Pharmacol Sci 19 (1998) 177-183
11. 3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization. Psychopharmacology 167 (2003) 363-372
12. 3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci 25 (2004) 618-625
13. 4 receptor ligands. Exp Opin Ther Patents 13 (2003) 851-865
14. 3 antagonists. J Med Chem 48 (2005) 2229-2238
15. Frost J.J. Imaging neuronal biochemistry by emission computed tomography: focus on neuroreceptors. Trends Pharmacol Sci 7 (1986) 490-496
16. Jones T. The role of positron emission tomography within the spectrum of medical imaging. Eur J Nucl Med 23 (1996) 207-211
17. Volkow N.D., Fowler J.S., Gatley S.J., Logan J., Wang G.J., Ding Y.S., et al. PET evaluation of the dopamine system of the human brain. J Nucl Med 37 (1996) 1242-1256
18. Volkow N.D., Rosen B., and Farde L. Imaging the living human brain: magnetic resonance imaging and positron emission tomography. Proc Natl Acad Sci U S A 94 (1997) 2787-2788
19. 11C]pyrilamine and positron emission tomography. J Neurochem 59 (1992) 128-136
20. 11C]doxepin and positron emission tomography. Neurosci Lett 137 (1992) 145-148
21. Yanai K., Watanabe T., Meguro K., Yokoyama H., Sato I., Sasano H., et al. Age-dependent decrease in histamine H1 receptor in human brains revealed by PET. Neuroreport 3 (1992) 433-436
22. 1 receptors in patients with Alzheimer's disease assessed by positron emission tomography. Neurosci 99 (2000) 721-729
23. 1 receptor binding in the brain of depressed patients. Eur J Neurosci 20 (2004) 803-810
24. Okamura N., Yanai K., Higuchi M., Sakai J., Iwata R., Ido T., et al. Functional neuro-imaging of cognition impaired by a classical antihistamine, d-chlorpheniramine. Br J Pharmacol 129 (2000) 115-123
25. 1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine. Br J Clin Pharmacol 52 (2001) 501-509
26. 11C-doxepin positron emission tomography. J Clin Pharmacol 44 (2004) 890-900
27. 11C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen. Br J Clin Pharmacol 61 (2006) 16-26
28. Yanai K., and Tashiro M. The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies. Pharmacol Ther 113 (2007) 1-15
29. 11C] UCL 1829. XIIth International Symposium on Radiopharmaceutical Chemistry, Uppsala/Sweden (June 15-19, 1997) (abstract) (1997) 605-608
30. 3 receptor. Bioorg Med Chem 7 (1999) 1761-1767
31. 11C]benzyl]-morpholine: evaluation of a potential PET ligand. Nucl Med Biol 33 (2006) 801-810
32. 3 receptor. J Med Chem 39 (1996) 1220-1226
33. 3 receptor antagonists with high potency and selectivity. XIIth Int Congress Pharmacol. Abstract No. P.13.14.001 (1994)
34. 3 receptors. J Labelled Compd Radiopharm 43 (2000) 873-882
35. 3 receptors in vitro and in vivo. Proc Natl Acad Sci 100 (2003) 11086-11091
36. 11C]Ro15-4513 and its application in an extremely low concentration region to an ARG study. Nucl Med Biol 30 (2003) 335-343